- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2012 (2012), Article ID 839282, 7 pages
Osteoarticular Changes in Acromegaly
5th Department of Internal Medicine, University Hospital, Medical Faculty of Comenius University, Ružinovská 6, 821 06 Bratislava, Slovakia
Received 31 May 2012; Revised 11 July 2012; Accepted 5 August 2012
Academic Editor: Shih-Yi Lin
Copyright © 2012 Zdenko Killinger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. Giuseppina, B. Graziella, I. Laura et al., “Prevalence of osteoporosis and vertebral fractures in acromegalic patients,” Clinical Cases in Mineral and Bone Metabolism, vol. 8, no. 3, pp. 37–43, 2011.
- A. Tagliafico, E. Resmini, D. Ferone, and C. Martinoli, “Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations,” Radiologia Medica, vol. 116, no. 5, pp. 781–792, 2011.
- M. J. E. Wassenaar, N. R. Biermasz, N. A. T. Hamdy et al., “High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly,” European Journal of Endocrinology, vol. 164, no. 4, pp. 475–483, 2011.
- A. Colao, D. Ferone, P. Marzullo, and G. Lombardi, “Systemic complications of acromegaly: epidemiology, pathogenesis, and management,” Endocrine Reviews, vol. 25, no. 1, pp. 102–152, 2004.
- Y. Oh, H. L. Muller, H. Pham, and R. G. Rosenfeld, “Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells,” The Journal of Biological Chemistry, vol. 268, no. 35, pp. 26045–26048, 1993.
- N. R. Biermasz, A. M. Pereira, J. W. A. Smit, J. A. Romijn, and F. Roelfsema, “Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2731–2739, 2005.
- T. Ueland, S. L. Fougner, K. Godang, T. Schreiner, and J. Bollerslev, “Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients,” European Journal of Endocrinology, vol. 155, no. 5, pp. 709–715, 2006.
- M. Madiera, et al., “Effects of GH-IGF-1 excess and gonadal status on bone mineral density and body composition in patients with acromegaly,” Osteoporosis International, vol. 21, no. 12, pp. 2019–2025, 2010.
- S. A. Lieberman, A. G. Bjorkengren, and A. R. Hoffman, “Rheumatologic and skeletal changes in acromegaly,” Endocrinology and Metabolism Clinics of North America, vol. 21, no. 3, pp. 615–631, 1992.
- AACE Acromegaly Guidelines, “American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of acromegaly,” Endocrine Practice, vol. 17, supplement 4, pp. 636–6646, 2011.
- T. Ueland, “GH/IGF-I and bone resorption in vivo and in vitro,” European Journal of Endocrinology, vol. 152, no. 3, pp. 327–332, 2005.
- E. Mrak, I. Villa, R. Lanzi, M. Losa, F. Guidobono, and A. Rubinacci, “Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells,” Journal of Endocrinology, vol. 192, no. 3, pp. 639–645, 2007.
- F. J. A. De Paula, M. B. Góis-Júnior, M. H. Aguiar-Oliveira et al., “Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene,” Clinical Endocrinology, vol. 70, no. 1, pp. 35–40, 2009.
- H. D. White, A. M. Ahmad, A. A. Syed et al., “Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients,” Clinical Endocrinology, vol. 60, no. 4, pp. 516–526, 2004.
- M. Kužma, Z. Homerová, A. Dlesk et al., “Effect of growth hormone on bone status in growth hormone deficient adults,” Bratislavské lekárske listy. In press.
- C. Parkinson, M. Kassem, L. Heickendorff, A. Flyvbjerg, and P. J. Trainer, “Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5650–5655, 2003.
- A. Piovesan, M. Terzolo, G. Reimondo et al., “Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome,” Hormone and Metabolic Research, vol. 26, no. 5, pp. 234–237, 1994.
- H. Kaji, T. Sugimoto, D. Nakaoka et al., “Bone metabolism and body composition in Japanese patients with active acromegaly,” Clinical Endocrinology, vol. 55, no. 2, pp. 175–181, 2001.
- C. Ohlsson, B. Å. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg, “Growth hormone and bone,” Endocrine Reviews, vol. 19, no. 1, pp. 55–79, 1998.
- M. Bolanowski, J. Daroszewski, M. Mȩdraś, and B. Zadrozna-Śliwka, “Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function,” Journal of Bone and Mineral Metabolism, vol. 24, no. 1, pp. 72–78, 2006.
- W. Zgliczynski, M. Kochman, W. Misiorowski, and P. Zdunowski, “In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender,” Neuroendocrinology Letters, vol. 28, no. 5, pp. 621–628, 2007.
- T. Ueland, E. N. Ebbesen, J. S. Thomsen et al., “Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly,” European Journal of Clinical Investigation, vol. 32, no. 2, pp. 122–128, 2002.
- A. Scillitani, et al., “Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status,” Clinical Endocrinology, vol. 58, no. 6, pp. 725–731, 2003.
- A. Giustina, G. Mazziotti, and E. Canalis, “Growth hormone, insulin-like growth factors, and the skeleton,” Endocrine Reviews, vol. 29, no. 5, pp. 535–559, 2008.
- S. Bonadonna, G. Mazziotti, M. Nuzzo et al., “Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women,” Journal of Bone and Mineral Research, vol. 20, no. 10, pp. 1837–1844, 2005.
- N. R. Biermasz, N. A. T. Hamdy, A. M. Pereira, J. A. Romijn, and F. Roelfsema, “Long-term maintenance of the anabolic effects of GH on the skeleton in successful treated patients with acromegaly,” European Journal of Endocrinology, vol. 152, no. 1, pp. 53–60, 2005.
- Z. Killinger, J. Payer, I. Lazúrová et al., “Arthropathy in Acromegaly,” Rheumatic Disease Clinics of North America, vol. 36, no. 4, pp. 713–720, 2010.
- J. J. Chipman, A. F. Attanasio, M. A. Birkett, P. C. Bates, S. Webb, and S. W. J. Lamberts, “The safety profile of GH replacement therapy in adults,” Clinical Endocrinology, vol. 46, no. 4, pp. 473–481, 1997.
- A. G. Harris, Acromegaly and Its Management, Lippincott-Raven, Philadelphia, Pa, USA, 1996.
- M. J. E. Wassenaar, N. R. Biermasz, N. van Duinen et al., “High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study,” European Journal of Endocrinology, vol. 160, no. 3, pp. 357–365, 2009.
- N. R. Biermasz, S. W. Van Thiel, A. M. Pereira et al., “Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5369–5376, 2004.